|Bid||7.02 x 2200|
|Ask||7.03 x 4000|
|Day's Range||6.76 - 7.25|
|52 Week Range||0.17 - 18.77|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 06, 2021 - May 10, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||9.00|
With gains of 1,259% to 2,801%, these billion-dollar stocks have been unstoppable since early October.
Here's what Jim Cramer had to say about some of the stocks that callers offered up during the Mad Money "Lightning Round" Tuesday evening - Ocugen : "This is a good speculative stock," Cramer told the caller. The company used to be called Histogenics Corp. and is a clinical stage biopharmaceutical firm that is focused on discovering, developing and commercializing a pipeline of therapies for eye diseases. In this daily Japanese candlestick chart of OCGN, below, we find some interesting clues.
Investors need to pay close attention to Ocugen (OCGN) stock based on the movements in the options market lately.